Role of digoxin in controlling the ventricular rate during atrial fibrillation: a systematic review and a rethinking

Clicks: 258
ID: 6801
2014
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #139 of 242 articles by views in research reports in clinical cardiology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 242 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Role of digoxin in controlling the ventricular rate during atrial fibrillation: a systematic review and a rethinking Philippe Maury,1 Anne Rollin,1 Michel Galinier,1 Yves Juillière21University Hospital Rangueil, Toulouse, France; 2Institut Lorrain du Coeur de des Vaisseaux Louis Mathieu, Nancy, FranceAbstract: Although digitalis has been used since the last century, it seems to be in the process of being progressively abandoned. However, digoxin has demonstrated a large positive benefit in terms of reduction of morbidity in heart failure patients with sinus rhythm, while the sometimes-observed increase in mortality is dramatically reduced with low serum concentrations. Digoxin, which is the only digitalis currently available, remains one of three drugs used for rate control in atrial fibrillation. Even if digoxin alone is insufficient to provide rate control during exertion in most patients, the optimal cardiac rate both at rest and at exertion is still undetermined, as is the importance of achieving sufficient rate control in asymptomatic patients. Because of its low cost and the accumulated knowledge and expertise about prescription, digoxin probably will remain an undisputed medication for rate control for atrial fibrillation, especially for heart failure patients.Keywords: digitalis, heart failure, atrial fibrillation, heart rate
Reference Key
philippe2014roleresearch Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Philippe Maury;Anne Rollin;Michel Galinier;Yves Juillière and
Journal research reports in clinical cardiology
Year 2014
DOI
10.2147/RRCC.S44919
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.